CVS Health Pre-Tax Profit Margin 2012-2025 | CVS
Current and historical pre-tax profit margin for CVS Health (CVS) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. CVS Health pre-tax profit margin for the three months ending September 30, 2025 was .
| CVS Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $394.08B | $2.91B | 0.74% |
| 2025-06-30 | $386.64B | $6.50B | 1.68% |
| 2025-03-31 | $378.96B | $7.19B | 1.90% |
| 2024-12-31 | $372.81B | $6.15B | 1.65% |
| 2024-09-30 | $368.91B | $6.73B | 1.82% |
| 2024-06-30 | $363.25B | $9.64B | 2.65% |
| 2024-03-31 | $360.94B | $9.87B | 2.74% |
| 2023-12-31 | $357.78B | $11.17B | 3.12% |
| 2023-09-30 | $347.81B | $11.62B | 3.34% |
| 2023-06-30 | $339.20B | $4.16B | 1.22% |
| 2023-03-31 | $330.92B | $5.71B | 1.73% |
| 2022-12-31 | $322.47B | $5.84B | 1.81% |
| 2022-09-30 | $315.23B | $4.37B | 1.39% |
| 2022-06-30 | $307.86B | $10.96B | 3.56% |
| 2022-03-31 | $299.84B | $10.57B | 3.52% |
| 2021-12-31 | $292.11B | $10.54B | 3.61% |
| 2021-09-30 | $285.06B | $10.08B | 3.53% |
| 2021-06-30 | $278.32B | $9.74B | 3.50% |
| 2021-03-31 | $271.05B | $9.96B | 3.67% |
| 2020-12-31 | $268.71B | $9.77B | 3.64% |
| 2020-09-30 | $266.04B | $10.88B | 4.09% |
| 2020-06-30 | $263.80B | $11.21B | 4.25% |
| 2020-03-31 | $261.89B | $9.84B | 3.76% |
| 2019-12-31 | $256.78B | $9.00B | 3.50% |
| 2019-09-30 | $244.31B | $6.77B | 2.77% |
| 2019-06-30 | $226.99B | $6.53B | 2.88% |
| 2019-03-31 | $210.48B | $1.88B | 0.89% |
| 2018-12-31 | $194.58B | $1.41B | 0.72% |
| 2018-09-30 | $188.56B | $4.11B | 2.18% |
| 2018-06-30 | $187.25B | $4.28B | 2.28% |
| 2018-03-31 | $186.02B | $8.20B | 4.41% |
| 2017-12-31 | $184.79B | $8.27B | 4.47% |
| 2017-09-30 | $182.37B | $8.21B | 4.50% |
| 2017-06-30 | $180.81B | $8.61B | 4.76% |
| 2017-03-31 | $178.85B | $8.28B | 4.63% |
| 2016-12-31 | $177.55B | $8.64B | 4.86% |
| 2016-09-30 | $172.70B | $8.34B | 4.83% |
| 2016-06-30 | $166.73B | $7.94B | 4.76% |
| 2016-03-31 | $160.17B | $8.51B | 5.31% |
| 2015-12-31 | $153.29B | $8.62B | 5.62% |
| 2015-09-30 | $149.20B | $8.35B | 5.60% |
| 2015-06-30 | $145.58B | $7.86B | 5.40% |
| 2015-03-31 | $143.01B | $7.81B | 5.46% |
| 2014-12-31 | $139.37B | $7.68B | 5.51% |
| 2014-09-30 | $135.14B | $7.57B | 5.60% |
| 2014-06-30 | $132.05B | $8.03B | 6.08% |
| 2014-03-31 | $128.70B | $7.83B | 6.08% |
| 2013-12-31 | $126.76B | $7.53B | 5.94% |
| 2013-09-30 | $125.31B | $7.22B | 5.76% |
| 2013-06-30 | $123.61B | $6.87B | 5.56% |
| 2013-03-31 | $123.07B | $6.60B | 5.36% |
| 2012-12-31 | $123.12B | $6.31B | 5.12% |
| 2012-09-30 | $120.04B | $6.34B | 5.28% |
| 2012-06-30 | $116.48B | $6.09B | 5.23% |
| 2012-03-31 | $112.18B | $5.85B | 5.21% |
| 2011-12-31 | $107.08B | $5.75B | 5.37% |
| 2011-09-30 | $103.08B | $5.55B | 5.38% |
| 2011-06-30 | $100.12B | $5.46B | 5.45% |
| 2011-03-31 | $97.71B | $5.49B | 5.62% |
| 2010-12-31 | $95.78B | $5.60B | 5.85% |
| 2010-09-30 | $96.79B | $5.74B | 5.93% |
| 2010-06-30 | $97.72B | $5.84B | 5.98% |
| 2010-03-31 | $98.58B | $5.95B | 6.03% |
| 2009-12-31 | $98.22B | $5.90B | 6.01% |
| 2009-09-30 | $97.05B | $5.73B | 5.91% |
| 2009-06-30 | $93.27B | $5.64B | 6.05% |
| 2009-03-31 | $89.54B | $5.53B | 6.18% |
| 2008-12-31 | $87.47B | $5.54B | 6.33% |
| 2008-09-30 | $85.27B | $5.30B | 6.21% |
| 2008-06-30 | $84.90B | $5.09B | 5.99% |
| 2008-03-31 | $84.47B | $4.93B | 5.83% |
| 2007-12-31 | $76.33B | $4.36B | 5.71% |
| 2007-09-30 | $66.46B | $3.69B | 5.55% |
| 2007-06-30 | $57.17B | $3.01B | 5.26% |
| 2007-03-31 | $47.03B | $2.36B | 5.02% |
| 2006-12-31 | $43.82B | $2.23B | 5.08% |
| 2006-09-30 | $41.48B | $2.13B | 5.14% |
| 2006-06-30 | $39.25B | $2.08B | 5.31% |
| 2006-03-31 | $37.80B | $1.98B | 5.23% |
| 2005-12-31 | $37.01B | $1.91B | 5.16% |
| 2005-09-30 | $36.20B | $1.65B | 4.56% |
| 2005-06-30 | $35.14B | $1.54B | 4.38% |
| 2005-03-31 | $32.96B | $1.47B | 4.46% |
| 2004-12-31 | $30.59B | $1.40B | 4.56% |
| 2004-09-30 | $29.12B | $1.51B | 5.17% |
| 2004-06-30 | $27.59B | $1.51B | 5.48% |
| 2004-03-31 | $27.09B | $1.46B | 5.37% |
| 2003-12-31 | $26.59B | $1.38B | 5.18% |
| 2003-09-30 | $25.48B | $1.27B | 4.99% |
| 2003-06-30 | $24.98B | $1.23B | 4.93% |
| 2003-03-31 | $24.52B | $1.19B | 4.86% |
| 2002-12-31 | $24.18B | $1.16B | 4.78% |
| 2002-09-30 | $23.79B | $0.65B | 2.72% |
| 2002-06-30 | $23.32B | $0.59B | 2.51% |
| 2002-03-31 | $22.83B | $0.63B | 2.75% |
| 2001-12-31 | $22.24B | $0.71B | 3.19% |
| 2001-09-30 | $21.78B | $1.25B | 5.72% |
| 2001-06-30 | $21.29B | $1.31B | 6.14% |
| 2001-03-31 | $20.73B | $1.29B | 6.23% |
| 2000-12-31 | $20.09B | $1.24B | 6.19% |
| 2000-09-30 | $19.78B | $1.21B | 6.12% |
| 2000-06-30 | $19.18B | $1.15B | 6.01% |
| 2000-03-31 | $18.60B | $1.12B | 6.01% |
| 1999-12-31 | $18.10B | $1.08B | 5.95% |
| 1999-09-30 | $17.11B | $1.03B | 6.02% |
| 1999-06-30 | $16.52B | $1.00B | 6.06% |
| 1999-03-31 | $15.91B | $0.78B | 4.91% |
| 1998-12-31 | $15.27B | $0.71B | 4.66% |
| 1998-09-30 | $14.42B | $0.69B | 4.78% |
| 1998-06-30 | $14.42B | $0.64B | 4.47% |
| 1998-03-31 | $14.07B | $0.27B | 1.88% |
| 1997-12-31 | $13.87B | $0.15B | 1.11% |
| 1997-09-30 | $13.63B | $0.06B | 0.43% |
| 1997-06-30 | $12.54B | $0.00B | 0.02% |
| 1997-03-31 | $11.81B | $0.48B | 4.05% |
| 1996-12-31 | $9.67B | $0.40B | 4.18% |
| 1996-09-30 | $9.49B | $-0.57B | -6.04% |
| 1996-06-30 | $8.02B | $-0.65B | -8.05% |
| 1996-03-31 | $6.55B | $-0.73B | -11.13% |
| 1995-12-31 | $7.42B | $-0.80B | -10.76% |
| 1995-09-30 | $8.16B | $0.43B | 5.23% |
| 1995-06-30 | $9.73B | $0.52B | 5.32% |
| 1995-03-31 | $11.03B | $0.53B | 4.82% |
| 1994-12-31 | $11.29B | $0.58B | 5.13% |
| 1994-09-30 | $11.13B | $0.59B | 5.30% |
| 1994-06-30 | $10.75B | $0.58B | 5.37% |
| 1994-03-31 | $10.78B | $0.64B | 5.89% |
| 1993-12-31 | $10.44B | $0.60B | 5.74% |
| 1993-09-30 | $10.41B | $0.28B | 2.72% |
| 1993-06-30 | $10.45B | $0.31B | 2.97% |
| 1993-03-31 | $10.41B | $0.32B | 3.03% |
| 1992-12-31 | $10.43B | $0.34B | 3.21% |
| 1992-09-30 | $10.20B | $0.67B | 6.61% |
| 1992-06-30 | $10.13B | $0.67B | 6.57% |
| 1992-03-31 | $9.90B | $0.63B | 6.31% |
| 1991-12-31 | $9.89B | $0.64B | 6.47% |
| 1991-09-30 | $9.73B | $0.64B | 6.56% |
| 1991-06-30 | $9.44B | $0.65B | 6.87% |
| 1991-03-31 | $9.12B | $0.67B | 7.39% |
| 1990-12-31 | $8.69B | $0.69B | 7.91% |
| 1990-09-30 | $8.11B | $0.69B | 8.55% |
| 1990-06-30 | $7.92B | $0.71B | 8.93% |
| 1990-03-31 | $7.64B | $0.68B | 8.87% |
| 1989-12-31 | $7.55B | $0.70B | 9.32% |
| 1989-09-30 | $7.33B | $0.60B | 8.14% |
| 1989-06-30 | $7.12B | $0.59B | 8.23% |
| 1989-03-31 | $6.92B | $0.59B | 8.49% |
| 1988-12-31 | $6.78B | $0.59B | 8.64% |
| 1988-09-30 | $6.50B | $0.54B | 8.35% |
| 1988-06-30 | $6.27B | $0.53B | 8.37% |
| 1988-03-31 | $6.25B | $0.54B | 8.66% |
| 1987-12-31 | $5.93B | $0.52B | 8.75% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $99.460B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.002B | 27.77 |
| HCA Healthcare (HCA) | United States | $114.483B | 17.75 |
| Elevance Health (ELV) | United States | $75.335B | 11.24 |
| Cencora (COR) | United States | $69.692B | 21.99 |
| Natera (NTRA) | United States | $28.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.132B | 21.37 |
| Labcorp Holdings (LH) | United States | $22.980B | 17.52 |
| Viatris (VTRS) | United States | $16.793B | 6.26 |
| Medpace Holdings (MEDP) | United States | $15.268B | 37.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.244B | 0.00 |
| Solventum (SOLV) | United States | $13.550B | 13.15 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.161B | 12.07 |
| CochLear (CHEOY) | Australia | $11.774B | 0.00 |
| Revvity (RVTY) | United States | $11.518B | 20.04 |
| Charles River Laboratories (CRL) | United States | $9.312B | 17.93 |
| Sonic Healthcare (SKHHY) | Australia | $7.878B | 0.00 |
| Avantor (AVTR) | United States | $7.677B | 11.73 |
| BrightSpring Health Services (BTSG) | United States | $7.156B | 42.67 |
| HealthEquity (HQY) | United States | $6.788B | 25.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.207B | 0.00 |
| PACS (PACS) | United States | $6.058B | 36.84 |
| Bausch + Lomb (BLCO) | Canada | $6.022B | 39.53 |
| Sotera Health (SHC) | United States | $5.043B | 24.32 |
| Alignment Healthcare (ALHC) | United States | $4.352B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.012B | 18.80 |
| GeneDx Holdings (WGS) | United States | $2.436B | 42.79 |
| Organon (OGN) | United States | $2.134B | 2.25 |
| Establishment Labs Holdings (ESTA) | United States | $1.999B | 0.00 |
| Progyny (PGNY) | United States | $1.892B | 37.20 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Surgery Partners (SGRY) | United States | $1.754B | 22.60 |
| Ardent Health (ARDT) | United States | $1.280B | 4.18 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.001B | 16.36 |
| Teladoc Health (TDOC) | United States | $0.889B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.828B | 13.56 |
| Nutex Health (NUTX) | United States | $0.706B | 5.40 |
| Omada Health (OMDA) | United States | $0.675B | 0.00 |
| Embecta (EMBC) | United States | $0.643B | 3.59 |
| Sonida Senior Living (SNDA) | United States | $0.642B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.563B | 25.30 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.466B | 8.57 |
| CryoPort (CYRX) | United States | $0.437B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.409B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| So-Young (SY) | China | $0.339B | 0.00 |
| Agilon Health (AGL) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.262B | 0.00 |
| Oncology Institute (TOI) | United States | $0.257B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| LifeMD (LFMD) | United States | $0.151B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.097B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.070B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.10 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |